Sino Biopharma Invests in Karolinska; Deals Ahead?

Sino Biopharmaceutical will make an investment of up to $128.5 million in Karolinska Development AB, a Stockholm firm that supports translational drug development in Scandinavia. Typically, Karolinska invests in innovative academic-based concepts, bringing them to a point where they can be partnered. It currently has at least a dozen companies in its portfolio. According to Karolinska, it wanted to have a "strong Asian specialist investor" in life science, with the clear implication that future deals would be made between the two companies.

Help employers find you! Check out all the jobs and post your resume.